Back to LA LINDEN ADVISORS LP
SASAREPTA THERAPEUTICS INC
Showing 0 of 3 quarters
Position history for LALINDEN ADVISORS LP's holdings in SAREPTA THERAPEUTICS INC
As of its Q4 2022 13F, Linden Advisors held 106,250,000 shares of SAREPTA THERAPEUTICS, worth $122.9M. Linden Advisors' 13F filings listed SAREPTA THERAPEUTICS from Q3 2022 to Q4 2022, 2 quarterly filings. SAREPTA THERAPEUTICS was 1.3% of Linden Advisors' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.